-
The president wants to set minimum staffing levels for the beleaguered nursing home industry. But, given a lack of transparency surrounding industry’s finances, it’s a mystery how facilities will shoulder the costs.
-
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.
-
State Medicaid agencies for months have been preparing for the end of a federal mandate that has prevented states from removing people from the safety-net program during the pandemic.
-
The administration is ending several Trump-era policies that restricted enrollment. Federal officials say states can no longer charge premiums to low-income residents enrolled in Medicaid and have ruled out work requirements.
-
Among the 764 hospitals hit with a 1% reduction in payments for having high numbers of infections and avoidable complications are more than three dozen Medicare ranks among the nation's best.
-
Medicare billing codes for audio-only follow-up check-ins are leadng to new reimbursement battles.
-
U.S. District Judge M. Casey Rodgers wrote that the state had not shown “irreparable harm” to justify an injunction or temporary restraining order.
-
Guidelines released last week by the Centers for Medicare & Medicaid Services allow all visitors, excluding those that have recently tested positive for the coronavirus.
-
The federal government directed nursing homes to open their doors wide to visitors, easing many remaining pandemic restrictions.
-
An alternative to original Medicare, the private plans are run mostly by major insurers. A recent analysis estimates Medicare overpaid these insurers by $106 billion from 2010 through 2019.